We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Top Buys

Rank Stock Value
1
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$74.4M
2
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$42.5M
3
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$24.2M
4
SMH icon
VanEck Semiconductor ETF
SMH
+$17.4M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$12.9M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$105M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$12.8M
4
MSFT icon
Microsoft
MSFT
+$12.8M
5
AAPL icon
Apple
AAPL
+$11.9M

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUBG icon
2001
HUB Group
HUBG
$2.92B
$26K ﹤0.01%
1,230
+702
+133% +$14.7K
IDT icon
2002
IDT Corp
IDT
$1.62B
$26K ﹤0.01%
+2,716
New +$20K
INDP icon
2003
Indaptus Therapeutics
INDP
$157M
$26K ﹤0.01%
+3
New +$37.8K
INTU icon
2004
Intuit
INTU
$89B
$26K ﹤0.01%
98
-5,055
-98% -$1.28M
KBE icon
2005
State Street SPDR S&P Bank ETF
KBE
$1.71B
$26K ﹤0.01%
600
+454
+311% +$19.7K
LE icon
2006
Lands' End
LE
$403M
$26K ﹤0.01%
+2,164
New +$32.7K
LFVN icon
2007
LifeVantage
LFVN
$85.3M
$26K ﹤0.01%
2,061
+531
+35% +$6.31K
LGND icon
2008
Ligand Pharmaceuticals
LGND
$6.36B
$26K ﹤0.01%
365
+238
+187% +$17.5K
NMFC icon
2009
New Mountain Finance
NMFC
$732M
$26K ﹤0.01%
1,860
-13,066
-88% -$183K
NVS icon
2010
Novartis
NVS
$297B
$26K ﹤0.01%
285
-1,162
-80% -$98.3K
PBH icon
2011
Prestige Consumer Healthcare
PBH
$2.6B
$26K ﹤0.01%
826
-4,750
-85% -$141K
PFG icon
2012
Principal Financial Group
PFG
$24.3B
$26K ﹤0.01%
450
-9,890
-96% -$545K
PODD icon
2013
Insulet
PODD
$9.79B
$26K ﹤0.01%
217
-526
-71% -$53.9K
TBBK icon
2014
The Bancorp
TBBK
$2.84B
$26K ﹤0.01%
2,969
+876
+42% +$8.06K
TEF
2015
DELISTED
Telefonica
TEF
$26K ﹤0.01%
3,807
-13,271
-78% -$88.2K
TGI
2016
DELISTED
Triumph Group
TGI
$26K ﹤0.01%
1,150
-24
-2% -$516
TVTX icon
2017
Travere Therapeutics
TVTX
$5.78B
$26K ﹤0.01%
+1,309
New +$25.8K
VOT icon
2018
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.8B
$26K ﹤0.01%
172
+167
+3,340% +$24.4K
WGO icon
2019
Winnebago Industries
WGO
$909M
$26K ﹤0.01%
662
-18,260
-97% -$642K
NUAN
2020
DELISTED
Nuance Communications, Inc.
NUAN
$26K ﹤0.01%
+1,854
New +$27.3K
MR
2021
DELISTED
Montage Resources Corporation Common Stock
MR
$26K ﹤0.01%
+4,242
New +$42.3K
BGC icon
2022
BGC Group
BGC
$4.89B
$25K ﹤0.01%
+4,816
New +$25K
EIDO icon
2023
iShares MSCI Indonesia ETF
EIDO
$501M
$25K ﹤0.01%
963
-431
-31% -$10.9K
EQBK icon
2024
Equity Bancshares
EQBK
$1.05B
$25K ﹤0.01%
+938
New +$25K
ETON icon
2025
Eton Pharmaceutcials
ETON
$1.22B
$25K ﹤0.01%
3,139
+1,728
+122% +$13.4K
79 80
81
82 83

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.